Another report demonstrated that AF-HF001, a clinical drug candidate for heart failure, reversed the up-regulation of NDUFS5 expression in H9c2 rat cardiomyocytes and attenuated ROS production and myocardial cell apoptosis [36]. Here, NDUFS5 is linked to atrial fibrillation.